Skip to main content
English
中文
Log In
Log in
Log in with ORCID
NTU Single Sign On
Have you forgotten your password?
Home
.National Taiwan University / 國立臺灣大學
Project / 研究計畫
Investigate the Feasibility of Chitinase-3-Like-1 (Chi3l1) Specific Antibody and Its Antigen Recognition Sites as a Novel Diagnostic Medication for Epithelial Ovarian Cancer
Investigate the Feasibility of Chitinase-3-Like-1 (Chi3l1) Specific Antibody and Its Antigen Recognition Sites as a Novel Diagnostic Medication for Epithelial Ovarian Cancer
Details
Primary Data
Project title
探討以卵巢癌特異性抗體CHI3L1及其抗原辨識區作為卵巢癌診斷藥物之可行性
Internal ID
MOST109-2623-E002-004-NU
Principal Investigator
YING-CHENG CHIANG
Start Date
January 1, 2020
End Date
December 31, 2020
Organizations
Obstetrics & Gynecology
Partner Organizations
National Science and Technology Council